Amgen
American multinational biopharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Amgen Inc.?
Summarize this article for a 10 year old
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.[3][4] One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000[5] (8.5% of total city employment)[6] and included hundreds of scientists, making Amgen the largest employer in Ventura County.[7][8] As of 2022, Amgen has approximately 24,000 staff in total.[9]
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (August 2020) |
Formerly | Applied Molecular Genetics (1980–1983) |
---|---|
Company type | Public |
ISIN | US0311621009 |
Industry | Biotechnology |
Founded | April 8, 1980; 44 years ago (1980-04-08) |
Headquarters | Thousand Oaks, California, U.S. |
Key people | Robert A. Bradway (chairman, president & CEO) |
Products | |
Revenue | US$28.19 billion (2023) |
US$7.897 billion (2023) | |
US$6.717 billion (2023) | |
Total assets | US$97.15 billion (2023) |
Total equity | US$6.232 billion (2023) |
Number of employees | c. 26,700 (2023) |
Website | amgen |
Footnotes / references [1][2] |
In 2019, the company's largest selling products were Enbrel (etanercept),[10] a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases, and Neulasta (pegfilgrastim), an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy.[11] Other marketed products include Evenity (romosozumab-aqqg), Otezla (apremilast), Prolia (denosumab), Repatha (evolocumab), and Lumakras (sotorasib).